Qiagen, Inc.: FDA filings under this applicant name
FDA lists 2 510(k) clearances under 2 spellings of the applicant name “Qiagen, Inc.” (first 2014, latest 2018), plus 4 PMA and 1 De Novo decisions, across 6 product codes in 3 review panels. Median 510(k) review time under this name: 128 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2014 | 1 | 87 |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 1 | 168 |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Qiagen, Inc. took a median 168 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 168 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| PSU | Jak2 Gene Mutation Detection Test | 2 | 1 |
| MAQ | Kit, Dna Detection, Human Papillomavirus | 1 | 0 |
| NCD | Test, Immunity, Cell Mediated, Mycobacterium Tuberculosis | 1 | 0 |
| OQO | Herpes Simplex Virus Nucleic Acid Amplification Assay | 1 | 1 |
| PAB | Cytomegalovirus (Cmv) Dna Quantitative Assay | 1 | 0 |
| QBB | Placental Alpha Microglobulin-1 Immunoassay | 1 | 0 |
Review panels
- Microbiology (4)
- Pathology (2)
- Clinical Toxicology (1)
Most recent Qiagen, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K172287 | ipsogen JAK2 RGQ PCR Kit | PSU | 2018-01-12 | 168 |
| K142738 | artus HSV-1/2 QS-RGQ MDx Kit | OQO | 2014-12-19 | 87 |
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P160052 | PMA | PartoSure test | 2018-04-11 |
| DEN160028 | De Novo | Jak2 Gene Mutation Detection Test | 2017-03-27 |
| P130027 | PMA | ARTUS CMV RGQ MDX KIT | 2014-06-02 |
| P010033 | PMA | QUANTTFERON-TB GOLD AND TB GOLD-IN-THE-TUBE | 2001-11-28 |
| P880009 | PMA | VIRAPAP HUMAN PAPILLOMAVIRUS DNA DETECTION KIT | 1988-12-23 |
Recalls
1 product recalls in 1 recall events; 0 initiated in the last five years. Most recent: 2018-05-28.
3 product recalls in 2 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 0 initiated in the last five years. Most often: Cellestis Inc (2), Qiagen Sciences LLC (1).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
FDA spellings included
FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Qiagen, Inc. (5)
- Qiagen (2)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- QIAGEN GmbH (15 510(k)s)
- Qiagen Gaithersburg, Inc. (0 510(k)s)
- QIAGEN Manchester, Ltd. (0 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Qiagen, Inc.?
FDA lists 2 510(k) clearances under 2 spellings of the applicant name “Qiagen, Inc.” (first 2014, latest 2018), plus 4 PMA and 1 De Novo decisions, across 6 product codes in 3 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Qiagen, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Qiagen, Inc. is 128 days.
Which FDA product codes appear under Qiagen, Inc.?
The most frequent FDA product codes under this applicant name are PSU (Jak2 Gene Mutation Detection Test, 2); MAQ (Kit, Dna Detection, Human Papillomavirus, 1); NCD (Test, Immunity, Cell Mediated, Mycobacterium Tuberculosis, 1).
Next steps
- See all 2 Qiagen, Inc. clearances with predicates and recalls
- Run predicate analysis for product code PSU, Qiagen, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.